What Does Cosmetic Regulatory Due Diligence Check Before an EU Acquisition?
Regulatory due diligence identifies compliance gaps, regulatory liabilities and remediation costs before a cosmetic brand is acquired, helping investors make informed decisions about the transaction.
Acquiring a cosmetic brand can be an attractive investment opportunity. Established products, loyal customers, intellectual property and distribution networks often make cosmetic businesses appealing targets for investors, private equity firms and strategic buyers.
However, unlike many other consumer sectors, cosmetics are heavily regulated in the European Union. A brand that appears commercially successful may hide significant regulatory liabilities that could result in substantial costs after acquisition.
For this reason, regulatory due diligence has become an essential component of mergers and acquisitions involving cosmetic companies. A comprehensive regulatory assessment can reveal compliance gaps, identify hidden risks and provide a clear roadmap for bringing a portfolio into full compliance before the transaction is completed.
Why Is EU Cosmetic Regulatory Due Diligence Important When Acquiring a Brand?
Financial and commercial due diligence are standard elements of any acquisition process. Yet regulatory compliance is often overlooked until late in negotiations. This can be a costly mistake.
Under Regulation (EC) No 1223/2009 on cosmetic products, every cosmetic product placed on the European market must comply with specific safety, documentation, manufacturing and labelling requirements.
Non-compliance can lead to market withdrawals, product recalls, administrative sanctions, reputational damage and potential legal disputes.
From an investor’s perspective, acquiring a non-compliant cosmetic portfolio means inheriting regulatory liabilities that may require substantial remediation efforts. The cost of correcting deficiencies after acquisition can significantly affect the value of the transaction.
A dedicated regulatory due diligence exercise allows investors to quantify these risks before signing a deal.
How Do You Verify Cosmetic PIF Compliance During Acquisition Due Diligence?
One of the first aspects to assess during due diligence is the completeness and quality of the Product Information File (PIF).
Article 11 of Regulation (EC) No 1223/2009 requires that a PIF be maintained for every cosmetic product placed on the market. The file must be readily accessible to competent authorities and retained for ten years after the last batch has been placed on the market.
A due diligence review should verify:
- Presence of a PIF for every marketed product;
- Availability of the Cosmetic Product Safety Report (CPSR);
- Manufacturing method and GMP statement;
- Evidence supporting cosmetic claims;
- Animal testing declarations where applicable;
- Product descriptions consistent with marketed products.
A common issue encountered during acquisitions is the existence of incomplete PIFs prepared years earlier and never updated following formulation changes. In some cases, products are marketed despite lacking a valid safety assessment.
For investors, such findings may indicate substantial remediation costs.
How Do You Assess Cosmetic Product Safety Reports (CPSRs) During EU Cosmetic Due Diligence?
The CPSR represents the cornerstone of cosmetic compliance.
According to Annex I of Regulation (EC) No 1223/2009, every cosmetic product must undergo a documented safety assessment conducted by a qualified safety assessor.
Due diligence activities should evaluate:
- Qualifications of the safety assessor;
- Scientific robustness of toxicological evaluations;
- Ingredient exposure calculations;
- Margin of Safety assessments;
- Compliance with current SCCS opinions;
- Consideration of vulnerable population groups where relevant.
For example, a product assessed in 2018 may contain ingredients whose safety profile has subsequently changed due to new SCCS opinions or regulatory restrictions. Without reassessment, the product may no longer comply with current requirements.
Investors should therefore verify not only the existence of CPSRs but also their scientific validity and current relevance.
How Do You Review Ingredient Compliance During EU Cosmetic Regulatory Due Diligence?
Ingredient compliance is often one of the most critical areas of regulatory due diligence.
The review should verify conformity with:
- Annex II (prohibited substances);
- Annex III (restricted substances);
- Annex IV (colorants);
- Annex V (preservatives);
- Annex VI (UV filters);
of Regulation (EC) No 1223/2009.
In addition, attention should be paid to:
- REACH restrictions;
- Candidate List SVHC substances;
- Emerging regulatory concerns under CoRAP;
- Recent SCCS opinions;
- Nanomaterial requirements.
A practical example involves fragrances containing allergenic substances. Following recent amendments to the Cosmetics Regulation, additional fragrance allergens require declaration on product labels.
Brands that have not updated formulations or labelling may face future compliance challenges.
How Do You Verify GMP Compliance During EU Cosmetic Regulatory Due Diligence?
Article 8 of Regulation (EC) No 1223/2009 requires cosmetic products to be manufactured according to Good Manufacturing Practices.
Compliance is generally demonstrated through adherence to ISO 22716.
During due diligence, auditors should assess:
- Manufacturing procedures;
- Batch traceability;
- Quality control systems;
- Supplier qualification programs;
- Change control procedures;
- Complaint handling processes.
A company may possess strong sales performance while operating under weak GMP systems. In such situations, the acquisition risk extends beyond regulatory non-compliance and may affect product quality and business continuity.
How Do You Assess Cosmetic Labelling and Claims During EU Regulatory Due Diligence?
Labelling deficiencies are among the most frequently identified issues during cosmetic audits.
Articles 19 and 20 of Regulation (EC) No 1223/2009 establish mandatory labelling requirements, while Regulation (EU) No 655/2013 defines common criteria for cosmetic claims.
Regulatory due diligence should verify:
- Ingredient listings;
- Responsible Person details;
- Batch identification;
- Period After Opening (PAO);
- Precautionary statements;
- Country-specific language requirements.
Claims should also be assessed to ensure compliance with the six common criteria:
- Legal compliance;
- Truthfulness;
- Evidential support;
- Honesty;
- Fairness;
- Informed decision-making.
Marketing statements such as “clinically proven,” “hypoallergenic,” “free from chemicals,” or “toxin-free” frequently require closer scrutiny.
Failure to support claims adequately can expose investors to regulatory enforcement actions and consumer litigation risks.
How Do You Verify the Responsible Person and CPNP Compliance?
Every cosmetic product marketed in the European Union must have a designated Responsible Person.
Due diligence should verify:
- Identity of the Responsible Person;
- Contractual arrangements;
- Scope of responsibilities;
- Market surveillance procedures.
Notification status in the Cosmetic Product Notification Portal (CPNP) should also be reviewed.
It is not uncommon to discover products actively sold online despite never having been properly notified. Such deficiencies represent immediate compliance risks requiring correction before acquisition.
How Do You Assess Post-market Surveillance and Cosmetovigilance?
Article 23 of Regulation (EC) No 1223/2009 requires reporting of serious undesirable effects.
A regulatory due diligence project should evaluate:
- Complaint management systems;
- Adverse event reporting procedures;
- Corrective action records;
- Recall procedures;
- Communication with competent authorities.
An absence of documented cosmetovigilance activities may indicate systemic compliance weaknesses.
Investors should understand whether the target company possesses mature post-market surveillance systems capable of supporting future growth.
How Do You Review the Cosmetic Supply Chain and Regulatory Documentation?
Supply chain compliance has become increasingly important.
Regulatory experts should assess:
- Supplier qualification systems;
- Raw material specifications;
- Certificates of analysis;
- Technical documentation;
- Contract manufacturing agreements.
Particular attention should be paid to imported ingredients and finished products originating outside the European Union.
Documentation gaps often emerge when brands scale rapidly without corresponding investments in compliance infrastructure.
How Can Regulatory Findings Affect Cosmetic Brand Valuation?
One of the most valuable outcomes of regulatory due diligence is the ability to quantify compliance risks.
Findings can generally be categorised as:
- Critical deficiencies;
- Major deficiencies;
- Minor deficiencies;
- Improvement opportunities.
This classification allows investors to estimate remediation costs and integrate regulatory risks into valuation models.
For example, the discovery of missing CPSRs across an entire product portfolio may require a significant compliance project before products can continue to be marketed lawfully.
Such information can directly influence acquisition negotiations.
How Can Regulatory Experts Add Value Before Acquiring a Cosmetic Brand?
The objective of regulatory due diligence is not merely to identify problems.
Experienced regulatory consultants can also provide remediation strategies that transform compliance weaknesses into manageable action plans.
Services may include:
- Portfolio-wide compliance assessments;
- PIF reconstruction;
- CPSR updates;
- Ingredient compliance reviews;
- GMP gap analyses;
- Labelling corrections;
- Claims substantiation reviews;
- Responsible Person support.
By addressing deficiencies before acquisition, stakeholders can reduce uncertainty, accelerate integration and protect the long-term value of their investment.
Conclusion: What Does Cosmetic Regulatory Due Diligence Mean for an Acquisition?
In the cosmetics sector, regulatory compliance is a business asset that directly influences corporate value.
A cosmetic brand with incomplete documentation, outdated safety assessments or unsupported marketing claims may represent a far greater risk than financial statements alone suggest.
Comprehensive regulatory due diligence provides investors with a clear picture of compliance status, identifies hidden liabilities and creates a roadmap for remediation before acquisition.
As specialists in cosmetic regulatory affairs, safety assessment support and compliance management, we assist investors, private equity firms and strategic buyers in evaluating cosmetic brands across the European market.
Our due diligence services help ensure that regulatory risks are identified, quantified and resolved before they become costly post-acquisition liabilities.
Contact us and let us know about your projects.
Key Takeaways: What Should Investors Know About Cosmetic Regulatory Due Diligence Before Acquisition?
- Regulatory due diligence identifies compliance gaps, regulatory liabilities and potential remediation costs before acquiring a cosmetic brand.
- Reviews should cover PIFs, CPSRs, ingredient compliance, GMP, labelling and claims, Responsible Person and CPNP requirements.
- Post-market surveillance, cosmetovigilance, supply chain processes and regulatory documentation should also be assessed.
- Regulatory findings can be categorised as critical, major or minor deficiencies, or improvement opportunities, helping investors assess their impact on valuation.
- Addressing compliance deficiencies before acquisition can reduce uncertainty, support negotiations and protect the long-term value of the investment.
